Professor
Liepins, from the University of Newfoundland, has demonstrated, by means of
scanning electron microscopy, that after Ukrain treatment the lymphocytes
become capable of killing cancer cells.
These properties
have been proven in vitro, in vivo as well as
clinically.
One
of the most important mechanisms of Ukrain’s anti-tumor action is regulation of the
immune system and its effect on lymphocytes which enables them
to attack cancer cells.
Ukrain
increases the level of NK cells, corrects the number of T-helper and
T-suppressor cells and normalizes the T-helper/T-suppressor ratio. In mice
with implanted Lewis carcinoma Ukrain increased the levels of lymphocytes,
large granulocytes and mononuclear cells and activated macrophages [8,12,17,26].